LETROZOLE ASCENT letrozole 2.5 mg tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
27-11-2017

유효 성분:

letrozole, Quantity: 2.5 mg

제공처:

Medis Pharma Pty Ltd

INN (국제 이름):

Letrozole

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400

관리 경로:

Oral

패키지 단위:

30

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Treatment of postmenopausal women with hormone receptor positive breast cancer (see "Clinical Trials"). The safety and efficacy of neoadjuvant use has not been established. Letrozole is not indicated in hormone receptor negative disease.

제품 요약:

Visual Identification: Yellow to dark yellow round, film coated, biconvex tablet engraved with ' L' on one face and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2013-05-20